Merck & Co (NYSE: MRK)
DRUGS - Drug Manufacturers - Major
Health Care
Stock price data as of
Closing price: $84.71
-
Support level$82.14
-
Resistance levelN/A
-
Beta0.2
-
RSI (14-day)62.2
- With a -31.9 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.
- Up 5.9 percent, MRK is one of this week's biggest gainers.
- The price of this low-beta stock is expected to increase by 0.2 percent for every 1% increase in the S&P-500.
- Volatility is forecast to fall over the next month.
- Price broke above prior resistance level - a short-term bullish signal.
52-week low | 52-week high | Price as % of range |
---|---|---|
$73.47 | $127.78 | 25.7% |
200 day | 50 day | 20 day | 10 day |
---|---|---|---|
$90.81 | $79.76 | $81.98 | $82.28 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week5.9%
-
In the next month12.7%
-
In the next year54.4%
Period | Value |
---|---|
Historical (5 year) | 22.4% |
Last month | 21.0% |
Current estimate | 21.8% |
Next month forecast | 22.4% |